SANTA ROSA -- Osseon Therapeutics, Inc. today announced the commercial release in the U.S. of its newest device for treating bones and joints, following federal regulatory approval.

The U.S. Food and Drug Administration approved the Osseoflex SB steerable inflatable bone tamp, which aims to treat degenerative bone and joint problems such as vertebral compression fractures.

The Santa Rosa-based device maker said it recently completed a successful launch and distribution in Europe.

Osseon (707-636-5940, claims its patented, steerable delivery system offers more treatment options than other commercial solutions while offering significant advantages in procedural efficiency and cost.